Blog
RSS FeedPosted by Michael Wonder on 12 Jul 2021
SMC - July 2021 decisions
12 July 2021 - The SMC has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 10 May 2021
Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use
10 May 2021 - The Scottish Medicines Consortium accepted a treatment of colorectal cancer in patients with a gene mutation called ...
Posted by Michael Wonder on 10 May 2021
SMC - May 2021 decisions
10 May 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has announced today that ...
Posted by Michael Wonder on 13 Apr 2021
Four medicines accepted for use by NHS Scotland
13 April 2021 - The Scottish Medicines Consortium has approved NHS funding for four new medicines, including treatments for multiple ...
Posted by Michael Wonder on 12 Apr 2021
SMC - April 2021 decisions
12 April 2021 - Advice on four new medicines for use in conditions including multiple myeloma and severe migraine has today ...
Posted by Michael Wonder on 08 Mar 2021
SMC - March 2021 decisions
8 March 2021 - Medicines which can be used to treat a rare genetic disease in children and some cancer ...
Posted by Michael Wonder on 09 Feb 2021
Scottish Medicines Consortium accepts Prostap SR DCS & Prostap 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer
8 February 2021 - Takeda is pleased to announce that the Scottish Medicines Consortium has accepted Prostap SR DCS & ...
Posted by Michael Wonder on 09 Feb 2021
Scotland approves MS drug that was rejected in England and Wales
9 February 2021 - A drug that can reduce the number of relapses suffered by people with multiple sclerosis has been ...
Posted by Michael Wonder on 08 Feb 2021
SMC - February 2021 decisions
8 February 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 20 Jan 2021
Scotland backs Roche’s Rozlytrek for ROS1 lung cancer
19 January 2021 - The Scottish Medicines Consortium has given a green light to Roche’s Rozlytrek for a rare form ...
Posted by Michael Wonder on 18 Jan 2021
SMC - January 2021 decisions
18 January 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 07 Dec 2020
SMC - December 2020 decisions
7 December 2020 - Medicines which can be used to treat a form of blood cancer and a rare muscle ...
Posted by Michael Wonder on 12 Nov 2020
After NICE okay, Scots denied access to Vifor’s Veltassa
10 November 2020 - The SMC has ruled that there’s not enough evidence to support NHS funding of Vifor Pharma’s ...
Posted by Michael Wonder on 09 Nov 2020
New osteoporosis drug for women approved for use on NHS in Scotland
9 October 2020 - A new drug to treat women with severe cases of the bone disease osteoporosis has been ...
Posted by Michael Wonder on 09 Nov 2020
SMC - November 2020 decisions
9 November 2020 - Advice on eight new medicines for use in conditions including breast cancer, lung cancer and osteoporosis has ...